Invion Limited (ASX:IVX)
0.0970
-0.0010 (-1.03%)
May 15, 2025, 3:32 PM AEST
Invion Revenue
Invion had revenue of 1.47M AUD in the twelve months ending December 31, 2024, down -66.59% year-over-year. In the fiscal year ending June 30, 2024, Invion had annual revenue of 3.69M, down -10.00%.
Revenue (ttm)
1.47M
Revenue Growth
-66.59%
P/S Ratio
5.13
Revenue / Employee
366.46K
Employees
4
Market Cap
7.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.69M | -410.46K | -10.00% |
Jun 30, 2023 | 4.10M | 812.95K | 24.70% |
Jun 30, 2022 | 3.29M | 961.74K | 41.28% |
Jun 30, 2021 | 2.33M | -1.15M | -32.98% |
Jun 30, 2020 | 3.48M | -405.31K | -10.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Regis Healthcare | 1.10B |